Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CSPC Shanhaiguan Pharmaceutical is a China-based pharmaceutical manufacturer and a key subsidiary of the CSPC Pharmaceutical Group. Established in 1958 and located in Qinhuangdao, the company focuses on the production of chemical drug preparations, particularly adrenal corticosteroids, and traditional Chinese medicine (TCM) formulations. Its product portfolio includes widely used generic medications such as Prednisone and Dexamethasone, as well as over-the-counter respiratory treatments. The company operates multiple GMP-certified production lines for tablets, capsules, and granules, serving as a primary manufacturing site for its parent group's essential medicine segment. CSPC Shanhaiguan plays a significant role in the domestic supply chain for hormonal therapies and traditional herbal remedies in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanhaiguan Pharmaceutical.